| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
208,785,000 |
| Market
Cap: |
47.40(B) |
| Last
Volume: |
1,348,221 |
Avg
Vol: |
0 |
| 52
Week Range: |
$177.16 - $259.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 785 |
| Guru Rank Value : 1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile IQVIA Holdings is a provider of analytics, technology solutions, and clinical research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to its life science clients; Research and Development Solutions, which primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services; and Contract Sales and Medical Solutions, which provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the healthcare market.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
68,853 |
81,970 |
115,108 |
120,554 |
| Total Sell Value |
$17,072,068 |
$19,879,540 |
$26,755,079 |
$27,988,147 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
5 |
6 |
9 |
11 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bousbib Ari |
See Remarks |
• • – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
91,142 |
743,237 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2022-02-09 |
4 |
D |
$255.57 |
$968,099 |
D/D |
(3,788) |
11,018 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,114 |
14,806 |
|
- |
|
| Danhakl John G |
Director |
– • – |
2021-12-22 |
4 |
B |
$272.93 |
$2,729,300 |
I/I |
10,000 |
24,344 |
2.1 |
-22% |
|
| Danhakl John G |
Director |
– • – |
2021-12-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
24,000 |
14,344 |
|
- |
|
| Connaughton John |
Director |
– • – |
2021-12-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,865 |
0 |
|
- |
|
| Connaughton John |
Director |
– • – |
2021-12-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(62,390) |
0 |
|
- |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2021-10-25 |
4 |
S |
$256.93 |
$1,028 |
D/D |
(4) |
26,224 |
|
18% |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2021-09-23 |
4 |
B |
$262.82 |
$1,051 |
D/D |
4 |
26,228 |
2.66 |
-5% |
|
| Knightly Kevin C |
See Remarks |
• – – |
2021-08-16 |
4 |
S |
$250.00 |
$1,513,750 |
D/D |
(6,055) |
2,006 |
|
-10% |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2021-08-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,391) |
21,047 |
|
- |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2021-07-20 |
4 |
B |
$245.32 |
$3,189 |
D/D |
13 |
20,355 |
2.66 |
7% |
|
| Burt Carol |
Director |
– • – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
I/I |
934 |
3,904 |
|
- |
|
| Rittenmeyer Ronald A |
Director |
– • – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
12,828 |
|
- |
|
| Danhakl John G |
Director |
– • – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
I/I |
934 |
38,344 |
|
- |
|
| Goggins Colleen A |
Director |
– • – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
8,185 |
|
- |
|
| Leonard John M. |
Director |
– • – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
10,678 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2021-02-09 |
4 |
D |
$183.82 |
$6,616,601 |
D/D |
(35,995) |
652,095 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
97,577 |
688,090 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2021-02-09 |
4 |
D |
$183.82 |
$347,971 |
D/D |
(1,893) |
5,692 |
|
- |
|
| Sherbet Eric |
See Remarks |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,585 |
7,585 |
|
- |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,687 |
23,438 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2021-02-09 |
4 |
D |
$183.82 |
$658,627 |
D/D |
(3,583) |
21,094 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,207 |
24,677 |
|
- |
|
| Knightly Kevin C |
See Remarks |
• – – |
2021-02-09 |
4 |
D |
$183.82 |
$688,406 |
D/D |
(3,745) |
8,061 |
|
- |
|
490 Records found
|
|
Page 5 of 20 |
|
|
3.67 (1.64%) 
